---
title: Bone marrow-derived mesenchymal stromal cells obstruct AML-targeting CD8<sup>+</sup>â€‰clonal
  effector and CAR T-cell function while promoting a senescence-associated phenotype
date: '2024-01-17'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38231344/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240117170649&v=2.18.0
source: heidelberg[Affiliation]
description: Bone marrow mesenchymal stromal cells (MSCs) have been described as potent
  regulators of T-cell function, though whether they could impede the effectiveness
  of immunotherapy against acute myeloid leukemia (AML) is still under investigation.
  We examine whether they could interfere with the activity of leukemia-specific clonal
  cytotoxic T-lymphocytes (CTLs) and chimeric antigen receptor (CAR) T cells, as well
  as whether the immunomodulatory properties of MSCs could be associated with the
  ...
disable_comments: true
---
Bone marrow mesenchymal stromal cells (MSCs) have been described as potent regulators of T-cell function, though whether they could impede the effectiveness of immunotherapy against acute myeloid leukemia (AML) is still under investigation. We examine whether they could interfere with the activity of leukemia-specific clonal cytotoxic T-lymphocytes (CTLs) and chimeric antigen receptor (CAR) T cells, as well as whether the immunomodulatory properties of MSCs could be associated with the ...